poisar

Stock

Charles River Laboratories International, Inc. CRL

$227.78-0.22%

Overview

CRL market data

Price History

CRL price chart

Valuation & Profitability

Twelve Data
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$2.91
Diluted earnings per share over the trailing twelve months.
Beta
1.37
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$144.26 – $237.86
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $11.3K · P/B 3.16 · P/S 2.80.

Company news

10 captured
Charles River shares are trading higher amid sympathy with peer Medpace Holdings after the company reported Q2 financial results. Medpace's new business awards and net book-to-bill ratio suggests suggests industry growth.Benzinga · Jul 22, 2026, 9:06 PM
Global Clinical Trials Market to Reach $176.32 Billion by 2030 as AI and Decentralized Research Accelerate GrowthGlobenewswire Inc · Jul 15, 2026, 11:15 AM
Keysight To Rally Over 24%? Here Are 10 Top Analyst Forecasts For MondayBenzinga · Jul 13, 2026, 12:11 PM
Mizuho Maintains Neutral on Charles River, Raises Price Target to $230Benzinga · Jul 13, 2026, 11:01 AM
Morgan Stanley Maintains Overweight on Charles River, Raises Price Target to $260Benzinga · Jul 9, 2026, 4:45 PM
Global Cell and Gene Therapy CDMO Market Anticipating Remarkable Growth at a CAGR of ~24% by 2034 | DelveInsightGlobenewswire Inc · Jun 18, 2026, 5:15 PM
This Charles River Analyst Turns Bullish; Here Are Top 4 Upgrades For WednesdayBenzinga · Jun 17, 2026, 1:15 PM
Delta Air Lines To Rally Around 12%? Here Are 10 Top Analyst Forecasts For WednesdayBenzinga · Jun 17, 2026, 1:10 PM
Morgan Stanley Upgrades Charles River to Overweight, Raises Price Target to $220Benzinga · Jun 17, 2026, 1:00 PM
CLSA Upgrades Charles River to Outperform, Raises Price Target to $219Benzinga · May 29, 2026, 1:02 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock
Charles River Laboratories International, Inc. (CRL) stock — price, valuation & news | Poisar